Table 1.
Baseline characteristics of the study population
Variables | ||
---|---|---|
Age* | 45.3±13.3 | |
Gender (female) (%) | 52.2 | |
Travel distance to outpatient clinic* | 89±118 | |
Travel time to outpatient clinic* | 78±76 | |
Duration of disease (years)* | 6.6±5.6 | |
Lead time to diagnosis | 15.3±16.1 | |
Smoking status (%) | ||
Non-smoker | 36.7 | |
Former smoker | 27.3 | |
Current smoker | 36.0 | |
Outpatient visit last year* | 4.2±2.7 | |
Changed residence (%) | 7.5 | |
Transport to hospital (%) | ||
Own car | 50.0 | |
Public transport | 33.1 | |
Own car and public transport | 16.9 | |
Medication (%) | ||
ASA | 92.8 | |
Budesonide | 46.3 | |
Azathioprine | 61.3 | |
Anti-TNF | 25.0 | |
Adalimumab | 15.8 | |
Infliximab | 11.7 | |
Education (%) | ||
Low¥ | 48.1 | |
High§ | 51.9 | |
Household income (%) | ||
Low | 39.7 | |
Moderate | 86.3 | |
High | 13.7 | |
Crohn’s disease behavior (%) | ||
Complicated | 18.7 | |
Not complicated | 81.3 | |
Disease activity (%) | ||
Active | 36.49 | |
Remission | 64.0 |
*: Mean±SD; ¥: Education levels lower than high school degree; §: University and college degree; ASA: American Society of Anesthesiologist; SD: Standard deviation.